Report Categories
View AllRecent Articles
View All
Grace Therapeutics GRCE Gains 140 Support Holds at 207 20260520
What Largo Inc LGOs 074 Decline Means for Investors 20260520
First FNLC Q1 2026 Results Consistency Amid Uncertainty
FSP Q4 2025 Earnings Significant EPS Beat Masks Revenue Disclosures
DOX Q1 2026 Earnings Narrow EPS Miss Weighs on Sentiment as Revenue Picture Remains Unclear
ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70
INCY Q1 2026 Earnings Strong Earnings Beat Driven by Robust Pipeline Progress
TONX Q1 2026 Earnings Significant EPS Beat Drives 458 Stock Gain
Galectin Therapeutics GALT Edges Lower Support Levels in Focus After 195 Decline
BioNTech and Bristol Myers Squibbs Bispecific Pumitamig Shows Encouraging Efficacy in FirstLine NonSmall Cell Lung Cancer
CVM Q4 2024 Earnings EPS Beat Amid No Revenue Stock Climbs 405
Charter Communications to Acquire Liberty Broadband in Improved Buyout Deal
External Links
SRBK Q3 2025 Earnings Positive EPS of 006 Stock Advances 243
Oxford Lane Capital Preferred OXLCO Creeps Higher as Yield Hunters Step In
CHS Inc CHSCL Slips Marginally While Holding Key Support Zone
Brookdale Senior Living BKD Faces Resistance After Modest Decline Despite Sector Tailwinds
Morgan Stanley MS Advances 2 Amid Renewed Financial Sector Optimism
Ryde Group RYDE Slides 74 as Selling Pressure Mounts Near 1 Support
Geospace Technologies Slides 47 Testing Key Support as Oilfield Headwinds Persist
CID HoldCo Warrants DAICW Inch Up in Thin Trading Amid Stagnant Levels